Andere talen CNBX Pharmaceuticals Inc.

Aandelen

CNBX

US13764M2098

Vertraagde tijd OTC Markets Andere beurzen 19:08:20 26-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,00634 ^USD	-19,75%		-3,08%	-55,63%

16/04	CNBX Pharmaceuticals Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 29 februari 2024	CI
12/01	CNBX Pharmaceuticals Inc. rapporteert winstresultaten voor het eerste kwartaal eindigend op 30 november 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14-07-23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05-06-23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02-06-23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14-04-23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14-04-23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08-02-23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08-02-23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13-01-23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13-01-23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29-12-22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29-12-22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30-11-22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30-11-22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30-11-22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08-11-22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08-11-22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CNBX Pharmaceuticals Inc.

Aandelen

CNBX

US13764M2098

Andere talen

Filters